Orbimed Advisors - JANUX THERAPEUTICS INC ownership

JANUX THERAPEUTICS INC's ticker is JANX and the CUSIP is 47103J105. A total of 45 filers reported holding JANUX THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Orbimed Advisors ownership history of JANUX THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$33,444,704
-0.7%
3,317,927
+17.0%
0.71%
+16.4%
Q2 2023$33,667,902
-1.9%
2,836,3860.0%0.61%
-9.5%
Q1 2023$34,320,271
-8.1%
2,836,3860.0%0.67%
-5.7%
Q4 2022$37,355,204
-2.7%
2,836,3860.0%0.72%
+0.3%
Q3 2022$38,405,000
+10.9%
2,836,3860.0%0.71%
+13.5%
Q2 2022$34,632,000
-14.9%
2,836,3860.0%0.63%
-4.8%
Q1 2022$40,674,000
-27.3%
2,836,3860.0%0.66%
-8.2%
Q4 2021$55,962,000
-25.4%
2,836,386
-18.2%
0.72%
-12.7%
Q3 2021$74,978,000
-13.3%
3,466,3860.0%0.82%
-5.8%
Q2 2021$86,486,0003,466,3860.88%
Other shareholders
JANUX THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
RA Capital Management 8,670,644$187,546,0002.60%
5AM Venture Management, LLC 446,266$9,653,0001.96%
Samsara BioCapital, LLC 411,871$8,909,0001.40%
EcoR1 Capital, LLC 1,411,975$30,541,0001.06%
BVF INC/IL 1,017,314$22,005,0000.86%
Orbimed Advisors 3,466,386$74,978,0000.82%
Logos Global Management LP 247,122$4,811,0000.35%
Woodline Partners LP 300,031$6,490,0000.11%
Parkwood LLC 20,777$449,0000.05%
JANUS HENDERSON GROUP PLC 2,416,404$51,375,0000.02%
View complete list of JANUX THERAPEUTICS INC shareholders